nodes	percent_of_prediction	percent_of_DWPC	metapath
Mefloquine—CYP19A1—osteoporosis	0.429	1	CbGaD
Mefloquine—CYP19A1—Raloxifene—osteoporosis	0.111	0.372	CbGbCtD
Mefloquine—ABCB1—Ethinyl Estradiol—osteoporosis	0.0227	0.076	CbGbCtD
Mefloquine—CYP3A4—Calcitriol—osteoporosis	0.0211	0.0707	CbGbCtD
Mefloquine—CYP3A4—Estropipate—osteoporosis	0.0211	0.0707	CbGbCtD
Mefloquine—CYP2D6—Cholecalciferol—osteoporosis	0.0171	0.0573	CbGbCtD
Mefloquine—CYP3A4—Ergocalciferol—osteoporosis	0.0169	0.0565	CbGbCtD
Mefloquine—ABCB1—Conjugated Estrogens—osteoporosis	0.0167	0.0558	CbGbCtD
Mefloquine—ABCB1—Estradiol—osteoporosis	0.0146	0.049	CbGbCtD
Mefloquine—CYP3A4—Raloxifene—osteoporosis	0.0141	0.0472	CbGbCtD
Mefloquine—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0136	0.0455	CbGbCtD
Mefloquine—CYP3A4—Cholecalciferol—osteoporosis	0.0109	0.0364	CbGbCtD
Mefloquine—CYP3A4—Conjugated Estrogens—osteoporosis	0.00998	0.0334	CbGbCtD
Mefloquine—CYP3A4—Estradiol—osteoporosis	0.00876	0.0293	CbGbCtD
Mefloquine—Hypertension—Zoledronate—osteoporosis	0.000179	0.00107	CcSEcCtD
Mefloquine—Hypersensitivity—Alendronate—osteoporosis	0.000179	0.00107	CcSEcCtD
Mefloquine—Headache—Etidronic acid—osteoporosis	0.000178	0.00106	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000177	0.00106	CcSEcCtD
Mefloquine—Asthenia—Estropipate—osteoporosis	0.000177	0.00106	CcSEcCtD
Mefloquine—Visual impairment—Estradiol—osteoporosis	0.000177	0.00105	CcSEcCtD
Mefloquine—Chest pain—Zoledronate—osteoporosis	0.000176	0.00105	CcSEcCtD
Mefloquine—Arthralgia—Zoledronate—osteoporosis	0.000176	0.00105	CcSEcCtD
Mefloquine—Myalgia—Zoledronate—osteoporosis	0.000176	0.00105	CcSEcCtD
Mefloquine—Palpitations—Conjugated Estrogens—osteoporosis	0.000176	0.00105	CcSEcCtD
Mefloquine—Insomnia—Risedronate—osteoporosis	0.000176	0.00105	CcSEcCtD
Mefloquine—Anxiety—Zoledronate—osteoporosis	0.000176	0.00105	CcSEcCtD
Mefloquine—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000175	0.00105	CcSEcCtD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000175	0.00105	CcSEcCtD
Mefloquine—Paraesthesia—Risedronate—osteoporosis	0.000175	0.00104	CcSEcCtD
Mefloquine—Pruritus—Estropipate—osteoporosis	0.000174	0.00104	CcSEcCtD
Mefloquine—Discomfort—Zoledronate—osteoporosis	0.000174	0.00104	CcSEcCtD
Mefloquine—Asthenia—Alendronate—osteoporosis	0.000174	0.00104	CcSEcCtD
Mefloquine—Hypersensitivity—Ibandronate—osteoporosis	0.000174	0.00104	CcSEcCtD
Mefloquine—Dyspnoea—Risedronate—osteoporosis	0.000173	0.00104	CcSEcCtD
Mefloquine—Erythema multiforme—Estradiol—osteoporosis	0.000173	0.00103	CcSEcCtD
Mefloquine—Hypotension—Pamidronate—osteoporosis	0.000173	0.00103	CcSEcCtD
Mefloquine—Convulsion—Conjugated Estrogens—osteoporosis	0.000173	0.00103	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000172	0.00103	CcSEcCtD
Mefloquine—Fatigue—Ethinyl Estradiol—osteoporosis	0.000172	0.00103	CcSEcCtD
Mefloquine—Pruritus—Alendronate—osteoporosis	0.000172	0.00102	CcSEcCtD
Mefloquine—Dyspepsia—Risedronate—osteoporosis	0.000171	0.00102	CcSEcCtD
Mefloquine—Eye disorder—Estradiol—osteoporosis	0.000171	0.00102	CcSEcCtD
Mefloquine—Tinnitus—Estradiol—osteoporosis	0.000171	0.00102	CcSEcCtD
Mefloquine—Confusional state—Zoledronate—osteoporosis	0.00017	0.00102	CcSEcCtD
Mefloquine—Hypersensitivity—Calcitriol—osteoporosis	0.00017	0.00102	CcSEcCtD
Mefloquine—Flushing—Estradiol—osteoporosis	0.00017	0.00102	CcSEcCtD
Mefloquine—Cardiac disorder—Estradiol—osteoporosis	0.00017	0.00102	CcSEcCtD
Mefloquine—Chest pain—Conjugated Estrogens—osteoporosis	0.00017	0.00101	CcSEcCtD
Mefloquine—Arthralgia—Conjugated Estrogens—osteoporosis	0.00017	0.00101	CcSEcCtD
Mefloquine—Myalgia—Conjugated Estrogens—osteoporosis	0.00017	0.00101	CcSEcCtD
Mefloquine—Asthenia—Ibandronate—osteoporosis	0.000169	0.00101	CcSEcCtD
Mefloquine—Anxiety—Conjugated Estrogens—osteoporosis	0.000169	0.00101	CcSEcCtD
Mefloquine—Nausea—Etidronic acid—osteoporosis	0.000169	0.00101	CcSEcCtD
Mefloquine—Anaphylactic shock—Zoledronate—osteoporosis	0.000169	0.00101	CcSEcCtD
Mefloquine—Oedema—Zoledronate—osteoporosis	0.000169	0.00101	CcSEcCtD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000168	0.00101	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000168	0.00101	CcSEcCtD
Mefloquine—Diarrhoea—Estropipate—osteoporosis	0.000168	0.00101	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Risedronate—osteoporosis	0.000168	0.001	CcSEcCtD
Mefloquine—Fatigue—Risedronate—osteoporosis	0.000168	0.001	CcSEcCtD
Mefloquine—Insomnia—Pamidronate—osteoporosis	0.000167	0.000999	CcSEcCtD
Mefloquine—Pruritus—Ibandronate—osteoporosis	0.000167	0.000998	CcSEcCtD
Mefloquine—Angiopathy—Estradiol—osteoporosis	0.000166	0.000993	CcSEcCtD
Mefloquine—Shock—Zoledronate—osteoporosis	0.000166	0.000993	CcSEcCtD
Mefloquine—Paraesthesia—Pamidronate—osteoporosis	0.000166	0.000992	CcSEcCtD
Mefloquine—Diarrhoea—Alendronate—osteoporosis	0.000166	0.000991	CcSEcCtD
Mefloquine—Asthenia—Calcitriol—osteoporosis	0.000166	0.00099	CcSEcCtD
Mefloquine—Nervous system disorder—Zoledronate—osteoporosis	0.000166	0.00099	CcSEcCtD
Mefloquine—Thrombocytopenia—Zoledronate—osteoporosis	0.000165	0.000988	CcSEcCtD
Mefloquine—Mediastinal disorder—Estradiol—osteoporosis	0.000165	0.000986	CcSEcCtD
Mefloquine—Dyspnoea—Pamidronate—osteoporosis	0.000165	0.000985	CcSEcCtD
Mefloquine—Tachycardia—Zoledronate—osteoporosis	0.000165	0.000985	CcSEcCtD
Mefloquine—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000164	0.000982	CcSEcCtD
Mefloquine—Chills—Estradiol—osteoporosis	0.000164	0.000982	CcSEcCtD
Mefloquine—Somnolence—Pamidronate—osteoporosis	0.000164	0.000982	CcSEcCtD
Mefloquine—Skin disorder—Zoledronate—osteoporosis	0.000164	0.00098	CcSEcCtD
Mefloquine—Pruritus—Calcitriol—osteoporosis	0.000163	0.000977	CcSEcCtD
Mefloquine—Hyperhidrosis—Zoledronate—osteoporosis	0.000163	0.000976	CcSEcCtD
Mefloquine—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000163	0.000975	CcSEcCtD
Mefloquine—Diarrhoea—Raloxifene—osteoporosis	0.000163	0.000975	CcSEcCtD
Mefloquine—Dyspepsia—Pamidronate—osteoporosis	0.000163	0.000972	CcSEcCtD
Mefloquine—Dizziness—Estropipate—osteoporosis	0.000163	0.000972	CcSEcCtD
Mefloquine—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000163	0.000972	CcSEcCtD
Mefloquine—Oedema—Conjugated Estrogens—osteoporosis	0.000163	0.000972	CcSEcCtD
Mefloquine—Alopecia—Estradiol—osteoporosis	0.000162	0.000967	CcSEcCtD
Mefloquine—Diarrhoea—Ibandronate—osteoporosis	0.000161	0.000965	CcSEcCtD
Mefloquine—Decreased appetite—Pamidronate—osteoporosis	0.000161	0.00096	CcSEcCtD
Mefloquine—Mental disorder—Estradiol—osteoporosis	0.000161	0.000959	CcSEcCtD
Mefloquine—Dizziness—Alendronate—osteoporosis	0.00016	0.000958	CcSEcCtD
Mefloquine—Shock—Conjugated Estrogens—osteoporosis	0.00016	0.000956	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Pamidronate—osteoporosis	0.00016	0.000954	CcSEcCtD
Mefloquine—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000159	0.000953	CcSEcCtD
Mefloquine—Malnutrition—Estradiol—osteoporosis	0.000159	0.000953	CcSEcCtD
Mefloquine—Erythema—Estradiol—osteoporosis	0.000159	0.000953	CcSEcCtD
Mefloquine—Fatigue—Pamidronate—osteoporosis	0.000159	0.000952	CcSEcCtD
Mefloquine—Gastrointestinal pain—Risedronate—osteoporosis	0.000159	0.00095	CcSEcCtD
Mefloquine—Tachycardia—Conjugated Estrogens—osteoporosis	0.000159	0.000948	CcSEcCtD
Mefloquine—Urticaria—Ethinyl Estradiol—osteoporosis	0.000158	0.000947	CcSEcCtD
Mefloquine—Diarrhoea—Calcitriol—osteoporosis	0.000158	0.000944	CcSEcCtD
Mefloquine—Skin disorder—Conjugated Estrogens—osteoporosis	0.000158	0.000944	CcSEcCtD
Mefloquine—Hypotension—Zoledronate—osteoporosis	0.000158	0.000943	CcSEcCtD
Mefloquine—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000158	0.000942	CcSEcCtD
Mefloquine—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000158	0.000942	CcSEcCtD
Mefloquine—Dizziness—Raloxifene—osteoporosis	0.000158	0.000942	CcSEcCtD
Mefloquine—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000157	0.000939	CcSEcCtD
Mefloquine—Vomiting—Estropipate—osteoporosis	0.000156	0.000935	CcSEcCtD
Mefloquine—Dizziness—Ibandronate—osteoporosis	0.000156	0.000932	CcSEcCtD
Mefloquine—Rash—Estropipate—osteoporosis	0.000155	0.000927	CcSEcCtD
Mefloquine—Dermatitis—Estropipate—osteoporosis	0.000155	0.000926	CcSEcCtD
Mefloquine—Urticaria—Risedronate—osteoporosis	0.000155	0.000923	CcSEcCtD
Mefloquine—Headache—Estropipate—osteoporosis	0.000154	0.000921	CcSEcCtD
Mefloquine—Vomiting—Alendronate—osteoporosis	0.000154	0.000921	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000154	0.000919	CcSEcCtD
Mefloquine—Abdominal pain—Risedronate—osteoporosis	0.000154	0.000919	CcSEcCtD
Mefloquine—Body temperature increased—Risedronate—osteoporosis	0.000154	0.000919	CcSEcCtD
Mefloquine—Muscle spasms—Estradiol—osteoporosis	0.000153	0.000916	CcSEcCtD
Mefloquine—Rash—Alendronate—osteoporosis	0.000153	0.000913	CcSEcCtD
Mefloquine—Insomnia—Zoledronate—osteoporosis	0.000153	0.000913	CcSEcCtD
Mefloquine—Dermatitis—Alendronate—osteoporosis	0.000153	0.000912	CcSEcCtD
Mefloquine—Feeling abnormal—Pamidronate—osteoporosis	0.000152	0.00091	CcSEcCtD
Mefloquine—Hypotension—Conjugated Estrogens—osteoporosis	0.000152	0.000908	CcSEcCtD
Mefloquine—Headache—Alendronate—osteoporosis	0.000152	0.000907	CcSEcCtD
Mefloquine—Paraesthesia—Zoledronate—osteoporosis	0.000152	0.000906	CcSEcCtD
Mefloquine—Vomiting—Raloxifene—osteoporosis	0.000152	0.000906	CcSEcCtD
Mefloquine—Gastrointestinal pain—Pamidronate—osteoporosis	0.000151	0.000903	CcSEcCtD
Mefloquine—Dyspnoea—Zoledronate—osteoporosis	0.000151	0.0009	CcSEcCtD
Mefloquine—Rash—Raloxifene—osteoporosis	0.00015	0.000898	CcSEcCtD
Mefloquine—Dermatitis—Raloxifene—osteoporosis	0.00015	0.000897	CcSEcCtD
Mefloquine—Somnolence—Zoledronate—osteoporosis	0.00015	0.000897	CcSEcCtD
Mefloquine—Vomiting—Ibandronate—osteoporosis	0.00015	0.000897	CcSEcCtD
Mefloquine—Tremor—Estradiol—osteoporosis	0.000149	0.000893	CcSEcCtD
Mefloquine—Headache—Raloxifene—osteoporosis	0.000149	0.000892	CcSEcCtD
Mefloquine—Rash—Ibandronate—osteoporosis	0.000149	0.000889	CcSEcCtD
Mefloquine—Dermatitis—Ibandronate—osteoporosis	0.000149	0.000888	CcSEcCtD
Mefloquine—Dyspepsia—Zoledronate—osteoporosis	0.000149	0.000888	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000148	0.000885	CcSEcCtD
Mefloquine—Ill-defined disorder—Estradiol—osteoporosis	0.000148	0.000884	CcSEcCtD
Mefloquine—Headache—Ibandronate—osteoporosis	0.000148	0.000883	CcSEcCtD
Mefloquine—Insomnia—Conjugated Estrogens—osteoporosis	0.000147	0.000879	CcSEcCtD
Mefloquine—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000147	0.000878	CcSEcCtD
Mefloquine—Vomiting—Calcitriol—osteoporosis	0.000147	0.000878	CcSEcCtD
Mefloquine—Decreased appetite—Zoledronate—osteoporosis	0.000147	0.000877	CcSEcCtD
Mefloquine—Agitation—Estradiol—osteoporosis	0.000147	0.000876	CcSEcCtD
Mefloquine—Nausea—Estropipate—osteoporosis	0.000146	0.000873	CcSEcCtD
Mefloquine—Abdominal pain—Pamidronate—osteoporosis	0.000146	0.000873	CcSEcCtD
Mefloquine—Body temperature increased—Pamidronate—osteoporosis	0.000146	0.000873	CcSEcCtD
Mefloquine—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000146	0.000872	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000146	0.000871	CcSEcCtD
Mefloquine—Rash—Calcitriol—osteoporosis	0.000146	0.00087	CcSEcCtD
Mefloquine—Fatigue—Zoledronate—osteoporosis	0.000146	0.00087	CcSEcCtD
Mefloquine—Dermatitis—Calcitriol—osteoporosis	0.000146	0.00087	CcSEcCtD
Mefloquine—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000145	0.000866	CcSEcCtD
Mefloquine—Headache—Calcitriol—osteoporosis	0.000145	0.000865	CcSEcCtD
Mefloquine—Somnolence—Conjugated Estrogens—osteoporosis	0.000145	0.000864	CcSEcCtD
Mefloquine—Nausea—Alendronate—osteoporosis	0.000144	0.00086	CcSEcCtD
Mefloquine—Malaise—Estradiol—osteoporosis	0.000144	0.000859	CcSEcCtD
Mefloquine—Hypersensitivity—Risedronate—osteoporosis	0.000143	0.000856	CcSEcCtD
Mefloquine—Vertigo—Estradiol—osteoporosis	0.000143	0.000856	CcSEcCtD
Mefloquine—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000143	0.000855	CcSEcCtD
Mefloquine—Asthenia—Ethinyl Estradiol—osteoporosis	0.000143	0.000855	CcSEcCtD
Mefloquine—Syncope—Estradiol—osteoporosis	0.000143	0.000854	CcSEcCtD
Mefloquine—Nausea—Raloxifene—osteoporosis	0.000142	0.000846	CcSEcCtD
Mefloquine—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000141	0.000845	CcSEcCtD
Mefloquine—Pruritus—Ethinyl Estradiol—osteoporosis	0.000141	0.000843	CcSEcCtD
Mefloquine—Palpitations—Estradiol—osteoporosis	0.000141	0.000842	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.00014	0.000839	CcSEcCtD
Mefloquine—Fatigue—Conjugated Estrogens—osteoporosis	0.00014	0.000838	CcSEcCtD
Mefloquine—Nausea—Ibandronate—osteoporosis	0.00014	0.000838	CcSEcCtD
Mefloquine—Loss of consciousness—Estradiol—osteoporosis	0.00014	0.000837	CcSEcCtD
Mefloquine—Asthenia—Risedronate—osteoporosis	0.00014	0.000834	CcSEcCtD
Mefloquine—Feeling abnormal—Zoledronate—osteoporosis	0.000139	0.000832	CcSEcCtD
Mefloquine—Gastrointestinal pain—Zoledronate—osteoporosis	0.000138	0.000825	CcSEcCtD
Mefloquine—Hypertension—Estradiol—osteoporosis	0.000138	0.000823	CcSEcCtD
Mefloquine—Pruritus—Risedronate—osteoporosis	0.000138	0.000822	CcSEcCtD
Mefloquine—Nausea—Calcitriol—osteoporosis	0.000137	0.00082	CcSEcCtD
Mefloquine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000137	0.000816	CcSEcCtD
Mefloquine—Hypersensitivity—Pamidronate—osteoporosis	0.000136	0.000814	CcSEcCtD
Mefloquine—Myalgia—Estradiol—osteoporosis	0.000136	0.000811	CcSEcCtD
Mefloquine—Chest pain—Estradiol—osteoporosis	0.000136	0.000811	CcSEcCtD
Mefloquine—Arthralgia—Estradiol—osteoporosis	0.000136	0.000811	CcSEcCtD
Mefloquine—Anxiety—Estradiol—osteoporosis	0.000135	0.000808	CcSEcCtD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000135	0.000806	CcSEcCtD
Mefloquine—Urticaria—Zoledronate—osteoporosis	0.000134	0.000802	CcSEcCtD
Mefloquine—Discomfort—Estradiol—osteoporosis	0.000134	0.000801	CcSEcCtD
Mefloquine—Abdominal pain—Zoledronate—osteoporosis	0.000134	0.000798	CcSEcCtD
Mefloquine—Body temperature increased—Zoledronate—osteoporosis	0.000134	0.000798	CcSEcCtD
Mefloquine—Diarrhoea—Risedronate—osteoporosis	0.000133	0.000795	CcSEcCtD
Mefloquine—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000133	0.000795	CcSEcCtD
Mefloquine—Asthenia—Pamidronate—osteoporosis	0.000133	0.000793	CcSEcCtD
Mefloquine—Dizziness—Ethinyl Estradiol—osteoporosis	0.000132	0.000788	CcSEcCtD
Mefloquine—Confusional state—Estradiol—osteoporosis	0.000131	0.000784	CcSEcCtD
Mefloquine—Pruritus—Pamidronate—osteoporosis	0.000131	0.000782	CcSEcCtD
Mefloquine—Anaphylactic shock—Estradiol—osteoporosis	0.00013	0.000778	CcSEcCtD
Mefloquine—Oedema—Estradiol—osteoporosis	0.00013	0.000778	CcSEcCtD
Mefloquine—Urticaria—Conjugated Estrogens—osteoporosis	0.000129	0.000772	CcSEcCtD
Mefloquine—Dizziness—Risedronate—osteoporosis	0.000129	0.000768	CcSEcCtD
Mefloquine—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000129	0.000768	CcSEcCtD
Mefloquine—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000129	0.000768	CcSEcCtD
Mefloquine—Shock—Estradiol—osteoporosis	0.000128	0.000765	CcSEcCtD
Mefloquine—Nervous system disorder—Estradiol—osteoporosis	0.000128	0.000763	CcSEcCtD
Mefloquine—Tachycardia—Estradiol—osteoporosis	0.000127	0.000759	CcSEcCtD
Mefloquine—Vomiting—Ethinyl Estradiol—osteoporosis	0.000127	0.000758	CcSEcCtD
Mefloquine—Diarrhoea—Pamidronate—osteoporosis	0.000127	0.000756	CcSEcCtD
Mefloquine—Skin disorder—Estradiol—osteoporosis	0.000126	0.000755	CcSEcCtD
Mefloquine—Hyperhidrosis—Estradiol—osteoporosis	0.000126	0.000752	CcSEcCtD
Mefloquine—Rash—Ethinyl Estradiol—osteoporosis	0.000126	0.000752	CcSEcCtD
Mefloquine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000126	0.000751	CcSEcCtD
Mefloquine—Headache—Ethinyl Estradiol—osteoporosis	0.000125	0.000747	CcSEcCtD
Mefloquine—Hypersensitivity—Zoledronate—osteoporosis	0.000124	0.000743	CcSEcCtD
Mefloquine—Vomiting—Risedronate—osteoporosis	0.000124	0.000739	CcSEcCtD
Mefloquine—Rash—Risedronate—osteoporosis	0.000123	0.000733	CcSEcCtD
Mefloquine—Dermatitis—Risedronate—osteoporosis	0.000123	0.000732	CcSEcCtD
Mefloquine—Dizziness—Pamidronate—osteoporosis	0.000122	0.000731	CcSEcCtD
Mefloquine—Headache—Risedronate—osteoporosis	0.000122	0.000728	CcSEcCtD
Mefloquine—Asthenia—Zoledronate—osteoporosis	0.000121	0.000724	CcSEcCtD
Mefloquine—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.00012	0.000716	CcSEcCtD
Mefloquine—Pruritus—Zoledronate—osteoporosis	0.000119	0.000714	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000119	0.000708	CcSEcCtD
Mefloquine—Nausea—Ethinyl Estradiol—osteoporosis	0.000119	0.000708	CcSEcCtD
Mefloquine—Insomnia—Estradiol—osteoporosis	0.000118	0.000703	CcSEcCtD
Mefloquine—Vomiting—Pamidronate—osteoporosis	0.000118	0.000702	CcSEcCtD
Mefloquine—Paraesthesia—Estradiol—osteoporosis	0.000117	0.000698	CcSEcCtD
Mefloquine—Asthenia—Conjugated Estrogens—osteoporosis	0.000117	0.000697	CcSEcCtD
Mefloquine—Rash—Pamidronate—osteoporosis	0.000117	0.000697	CcSEcCtD
Mefloquine—Dermatitis—Pamidronate—osteoporosis	0.000116	0.000696	CcSEcCtD
Mefloquine—Dyspnoea—Estradiol—osteoporosis	0.000116	0.000693	CcSEcCtD
Mefloquine—Headache—Pamidronate—osteoporosis	0.000116	0.000692	CcSEcCtD
Mefloquine—Somnolence—Estradiol—osteoporosis	0.000116	0.000691	CcSEcCtD
Mefloquine—Diarrhoea—Zoledronate—osteoporosis	0.000116	0.00069	CcSEcCtD
Mefloquine—Nausea—Risedronate—osteoporosis	0.000116	0.00069	CcSEcCtD
Mefloquine—Pruritus—Conjugated Estrogens—osteoporosis	0.000115	0.000687	CcSEcCtD
Mefloquine—Dyspepsia—Estradiol—osteoporosis	0.000115	0.000685	CcSEcCtD
Mefloquine—Decreased appetite—Estradiol—osteoporosis	0.000113	0.000676	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Estradiol—osteoporosis	0.000112	0.000671	CcSEcCtD
Mefloquine—Fatigue—Estradiol—osteoporosis	0.000112	0.00067	CcSEcCtD
Mefloquine—Dizziness—Zoledronate—osteoporosis	0.000112	0.000667	CcSEcCtD
Mefloquine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000111	0.000665	CcSEcCtD
Mefloquine—Nausea—Pamidronate—osteoporosis	0.00011	0.000656	CcSEcCtD
Mefloquine—Dizziness—Conjugated Estrogens—osteoporosis	0.000108	0.000643	CcSEcCtD
Mefloquine—Vomiting—Zoledronate—osteoporosis	0.000107	0.000642	CcSEcCtD
Mefloquine—Feeling abnormal—Estradiol—osteoporosis	0.000107	0.000641	CcSEcCtD
Mefloquine—Rash—Zoledronate—osteoporosis	0.000106	0.000636	CcSEcCtD
Mefloquine—Gastrointestinal pain—Estradiol—osteoporosis	0.000106	0.000636	CcSEcCtD
Mefloquine—Dermatitis—Zoledronate—osteoporosis	0.000106	0.000636	CcSEcCtD
Mefloquine—Headache—Zoledronate—osteoporosis	0.000106	0.000632	CcSEcCtD
Mefloquine—Vomiting—Conjugated Estrogens—osteoporosis	0.000103	0.000618	CcSEcCtD
Mefloquine—Urticaria—Estradiol—osteoporosis	0.000103	0.000618	CcSEcCtD
Mefloquine—Abdominal pain—Estradiol—osteoporosis	0.000103	0.000615	CcSEcCtD
Mefloquine—Body temperature increased—Estradiol—osteoporosis	0.000103	0.000615	CcSEcCtD
Mefloquine—Rash—Conjugated Estrogens—osteoporosis	0.000103	0.000613	CcSEcCtD
Mefloquine—Dermatitis—Conjugated Estrogens—osteoporosis	0.000102	0.000612	CcSEcCtD
Mefloquine—Headache—Conjugated Estrogens—osteoporosis	0.000102	0.000609	CcSEcCtD
Mefloquine—Nausea—Zoledronate—osteoporosis	0.0001	0.000599	CcSEcCtD
Mefloquine—Nausea—Conjugated Estrogens—osteoporosis	9.66e-05	0.000577	CcSEcCtD
Mefloquine—Hypersensitivity—Estradiol—osteoporosis	9.59e-05	0.000573	CcSEcCtD
Mefloquine—Asthenia—Estradiol—osteoporosis	9.34e-05	0.000558	CcSEcCtD
Mefloquine—Pruritus—Estradiol—osteoporosis	9.21e-05	0.00055	CcSEcCtD
Mefloquine—Diarrhoea—Estradiol—osteoporosis	8.91e-05	0.000532	CcSEcCtD
Mefloquine—Dizziness—Estradiol—osteoporosis	8.61e-05	0.000514	CcSEcCtD
Mefloquine—Vomiting—Estradiol—osteoporosis	8.28e-05	0.000494	CcSEcCtD
Mefloquine—Rash—Estradiol—osteoporosis	8.21e-05	0.00049	CcSEcCtD
Mefloquine—Dermatitis—Estradiol—osteoporosis	8.2e-05	0.00049	CcSEcCtD
Mefloquine—Headache—Estradiol—osteoporosis	8.15e-05	0.000487	CcSEcCtD
Mefloquine—Nausea—Estradiol—osteoporosis	7.73e-05	0.000462	CcSEcCtD
Mefloquine—CYP19A1—Metabolism—ATIC—osteoporosis	4.87e-05	0.000464	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—CALCA—osteoporosis	4.86e-05	0.000464	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	4.75e-05	0.000453	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—ATIC—osteoporosis	4.73e-05	0.000451	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—PNP—osteoporosis	4.73e-05	0.000451	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—WNT1—osteoporosis	4.71e-05	0.00045	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—PTHLH—osteoporosis	4.69e-05	0.000448	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—TLN1—osteoporosis	4.69e-05	0.000448	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—MGLL—osteoporosis	4.59e-05	0.000438	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—OXCT1—osteoporosis	4.5e-05	0.00043	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—CA2—osteoporosis	4.5e-05	0.00043	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—LRP5—osteoporosis	4.48e-05	0.000428	CbGpPWpGaD
Mefloquine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—osteoporosis	4.45e-05	0.000425	CbGpPWpGaD
Mefloquine—CYP2D6—Biological oxidations—CYP19A1—osteoporosis	4.42e-05	0.000422	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—MGLL—osteoporosis	4.39e-05	0.000419	CbGpPWpGaD
Mefloquine—CYP2D6—Metapathway biotransformation—CYP19A1—osteoporosis	4.36e-05	0.000416	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—LRP6—osteoporosis	4.29e-05	0.000409	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—PTHLH—osteoporosis	4.26e-05	0.000407	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—CA2—osteoporosis	4.14e-05	0.000395	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—OXCT1—osteoporosis	4.14e-05	0.000395	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	4.14e-05	0.000395	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—CALCA—osteoporosis	4.13e-05	0.000394	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—P4HB—osteoporosis	4.05e-05	0.000386	CbGpPWpGaD
Mefloquine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	4.03e-05	0.000385	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—MGLL—osteoporosis	4.03e-05	0.000385	CbGpPWpGaD
Mefloquine—ADORA1—Circadian rythm related genes—IL6—osteoporosis	4.03e-05	0.000384	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of proteins—ACE—osteoporosis	4.03e-05	0.000384	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—OXCT1—osteoporosis	4.02e-05	0.000383	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—CA2—osteoporosis	4.02e-05	0.000383	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—PTH—osteoporosis	3.94e-05	0.000375	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—MGLL—osteoporosis	3.92e-05	0.000374	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—IL1B—osteoporosis	3.9e-05	0.000372	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—RAP1A—osteoporosis	3.87e-05	0.000369	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CNR2—osteoporosis	3.83e-05	0.000366	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—POMC—osteoporosis	3.83e-05	0.000365	CbGpPWpGaD
Mefloquine—CYP19A1—Integrated Breast Cancer Pathway—MYC—osteoporosis	3.82e-05	0.000364	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—ADCY5—osteoporosis	3.81e-05	0.000363	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—NFATC1—osteoporosis	3.77e-05	0.00036	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—CALCA—osteoporosis	3.75e-05	0.000358	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—DKK1—osteoporosis	3.74e-05	0.000357	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—IDH2—osteoporosis	3.73e-05	0.000356	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—ANXA2—osteoporosis	3.73e-05	0.000356	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	3.69e-05	0.000352	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—TLN1—osteoporosis	3.62e-05	0.000346	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—WNT1—osteoporosis	3.61e-05	0.000344	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of proteins—ACE—osteoporosis	3.59e-05	0.000343	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—CYP27A1—osteoporosis	3.51e-05	0.000335	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—FGA—osteoporosis	3.51e-05	0.000335	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—ADCY5—osteoporosis	3.46e-05	0.00033	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	3.44e-05	0.000329	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	3.43e-05	0.000328	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—IDH2—osteoporosis	3.43e-05	0.000327	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—ACP5—osteoporosis	3.41e-05	0.000326	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	3.37e-05	0.000322	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—IDH2—osteoporosis	3.33e-05	0.000318	CbGpPWpGaD
Mefloquine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	3.27e-05	0.000312	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—BMP2—osteoporosis	3.26e-05	0.000311	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—PTHLH—osteoporosis	3.26e-05	0.000311	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—CYP27A1—osteoporosis	3.22e-05	0.000308	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	3.21e-05	0.000306	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—FGB—osteoporosis	3.19e-05	0.000304	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—TPI1—osteoporosis	3.17e-05	0.000303	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—ACP5—osteoporosis	3.14e-05	0.000299	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—CYP27A1—osteoporosis	3.13e-05	0.000299	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—P4HB—osteoporosis	3.12e-05	0.000298	CbGpPWpGaD
Mefloquine—ADORA2A—Circadian rythm related genes—IL6—osteoporosis	3.11e-05	0.000297	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	3.1e-05	0.000295	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—PSMA2—osteoporosis	3.08e-05	0.000294	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—PSMA5—osteoporosis	3.08e-05	0.000294	CbGpPWpGaD
Mefloquine—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—osteoporosis	3.05e-05	0.000291	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—ACP5—osteoporosis	3.05e-05	0.000291	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—PTH—osteoporosis	3.04e-05	0.00029	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—TGFB1—osteoporosis	3.03e-05	0.000289	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	3.01e-05	0.000287	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—RAP1A—osteoporosis	2.99e-05	0.000285	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—P4HB—osteoporosis	2.98e-05	0.000285	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CNR2—osteoporosis	2.96e-05	0.000282	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—ADCY5—osteoporosis	2.94e-05	0.00028	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—GAPDH—osteoporosis	2.93e-05	0.000279	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—TPI1—osteoporosis	2.92e-05	0.000278	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—NFATC1—osteoporosis	2.91e-05	0.000278	CbGpPWpGaD
Mefloquine—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	2.89e-05	0.000276	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—DKK1—osteoporosis	2.89e-05	0.000276	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	2.88e-05	0.000275	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CALCA—osteoporosis	2.87e-05	0.000274	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—RAP1A—osteoporosis	2.85e-05	0.000272	CbGpPWpGaD
Mefloquine—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	2.85e-05	0.000272	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—TPI1—osteoporosis	2.83e-05	0.00027	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—TNF—osteoporosis	2.83e-05	0.00027	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—POMC—osteoporosis	2.8e-05	0.000267	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—WNT1—osteoporosis	2.78e-05	0.000266	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—P4HB—osteoporosis	2.74e-05	0.000262	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—FGA—osteoporosis	2.71e-05	0.000258	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—GAPDH—osteoporosis	2.69e-05	0.000257	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—ADCY5—osteoporosis	2.67e-05	0.000255	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—P4HB—osteoporosis	2.66e-05	0.000254	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PKM—osteoporosis	2.66e-05	0.000254	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—FDPS—osteoporosis	2.66e-05	0.000254	CbGpPWpGaD
Mefloquine—CYP2D6—Biological oxidations—POMC—osteoporosis	2.66e-05	0.000253	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—RAP1A—osteoporosis	2.62e-05	0.00025	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—GAPDH—osteoporosis	2.61e-05	0.000249	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—KL—osteoporosis	2.61e-05	0.000249	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—RAP1A—osteoporosis	2.54e-05	0.000243	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—POMC—osteoporosis	2.54e-05	0.000243	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PGLS—osteoporosis	2.52e-05	0.000241	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—GPD2—osteoporosis	2.52e-05	0.000241	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—PTHLH—osteoporosis	2.52e-05	0.00024	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—BMP2—osteoporosis	2.52e-05	0.00024	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—FDPS—osteoporosis	2.51e-05	0.000239	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PKM—osteoporosis	2.51e-05	0.000239	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of proteins—LEP—osteoporosis	2.5e-05	0.000239	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	2.49e-05	0.000238	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.49e-05	0.000237	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—IL6R—osteoporosis	2.48e-05	0.000237	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—FGB—osteoporosis	2.46e-05	0.000235	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—PSMA5—osteoporosis	2.38e-05	0.000227	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—PSMA2—osteoporosis	2.38e-05	0.000227	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—GPD2—osteoporosis	2.38e-05	0.000227	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PGLS—osteoporosis	2.38e-05	0.000227	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by NGF—IL6—osteoporosis	2.35e-05	0.000224	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—ENO1—osteoporosis	2.31e-05	0.00022	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PNP—osteoporosis	2.31e-05	0.00022	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—ATIC—osteoporosis	2.31e-05	0.00022	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.29e-05	0.000218	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—PSMA2—osteoporosis	2.27e-05	0.000217	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—PSMA5—osteoporosis	2.27e-05	0.000217	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of proteins—LEP—osteoporosis	2.23e-05	0.000213	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.22e-05	0.000212	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CALCA—osteoporosis	2.22e-05	0.000211	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—ATIC—osteoporosis	2.17e-05	0.000207	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PNP—osteoporosis	2.17e-05	0.000207	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—POMC—osteoporosis	2.16e-05	0.000206	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of proteins—POMC—osteoporosis	2.15e-05	0.000205	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—ENO1—osteoporosis	2.12e-05	0.000202	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—PSMA5—osteoporosis	2.09e-05	0.000199	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—PSMA2—osteoporosis	2.09e-05	0.000199	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of proteins—IGF1—osteoporosis	2.07e-05	0.000197	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—ENO1—osteoporosis	2.06e-05	0.000196	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—ADCY5—osteoporosis	2.04e-05	0.000195	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—PSMA2—osteoporosis	2.03e-05	0.000193	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—PSMA5—osteoporosis	2.03e-05	0.000193	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—KL—osteoporosis	2.01e-05	0.000192	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—SPP1—osteoporosis	1.98e-05	0.000188	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—POMC—osteoporosis	1.96e-05	0.000187	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CA2—osteoporosis	1.96e-05	0.000187	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—OXCT1—osteoporosis	1.96e-05	0.000187	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of proteins—POMC—osteoporosis	1.92e-05	0.000183	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—IL6R—osteoporosis	1.91e-05	0.000183	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—MGLL—osteoporosis	1.91e-05	0.000182	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—OXCT1—osteoporosis	1.85e-05	0.000176	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CA2—osteoporosis	1.85e-05	0.000176	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of proteins—IGF1—osteoporosis	1.84e-05	0.000176	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—CYP19A1—osteoporosis	1.84e-05	0.000176	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—MGLL—osteoporosis	1.8e-05	0.000172	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—IRS2—osteoporosis	1.79e-05	0.00017	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—LEP—osteoporosis	1.75e-05	0.000167	CbGpPWpGaD
Mefloquine—CYP3A4—Biological oxidations—POMC—osteoporosis	1.74e-05	0.000166	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—ESR1—osteoporosis	1.67e-05	0.000159	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—CYP19A1—osteoporosis	1.64e-05	0.000157	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—FDPS—osteoporosis	1.64e-05	0.000156	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PKM—osteoporosis	1.64e-05	0.000156	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—IDH2—osteoporosis	1.62e-05	0.000155	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—ADCY5—osteoporosis	1.58e-05	0.00015	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—IRS1—osteoporosis	1.56e-05	0.000149	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GPD2—osteoporosis	1.55e-05	0.000148	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PGLS—osteoporosis	1.55e-05	0.000148	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—IDH2—osteoporosis	1.53e-05	0.000146	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CYP27A1—osteoporosis	1.53e-05	0.000146	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—SPP1—osteoporosis	1.53e-05	0.000146	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—ADCY5—osteoporosis	1.51e-05	0.000144	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—POMC—osteoporosis	1.5e-05	0.000143	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—GPX1—osteoporosis	1.5e-05	0.000143	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	1.5e-05	0.000143	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	1.5e-05	0.000143	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—ACP5—osteoporosis	1.49e-05	0.000142	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—IL6R—osteoporosis	1.47e-05	0.00014	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—IGF1—osteoporosis	1.44e-05	0.000138	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CYP27A1—osteoporosis	1.44e-05	0.000137	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—ATIC—osteoporosis	1.42e-05	0.000136	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PNP—osteoporosis	1.42e-05	0.000136	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—ACP5—osteoporosis	1.4e-05	0.000134	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.4e-05	0.000134	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	1.4e-05	0.000133	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—MTHFR—osteoporosis	1.39e-05	0.000132	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—ADCY5—osteoporosis	1.38e-05	0.000132	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—TPI1—osteoporosis	1.38e-05	0.000132	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—IRS2—osteoporosis	1.38e-05	0.000132	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—GPX1—osteoporosis	1.38e-05	0.000132	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—LEP—osteoporosis	1.35e-05	0.000129	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—ADCY5—osteoporosis	1.34e-05	0.000128	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—GPX1—osteoporosis	1.34e-05	0.000128	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—TPI1—osteoporosis	1.3e-05	0.000124	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—P4HB—osteoporosis	1.3e-05	0.000124	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—ESR1—osteoporosis	1.29e-05	0.000123	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—GAPDH—osteoporosis	1.27e-05	0.000122	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—MTHFR—osteoporosis	1.27e-05	0.000121	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—RAP1A—osteoporosis	1.24e-05	0.000118	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—MTHFR—osteoporosis	1.24e-05	0.000118	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—P4HB—osteoporosis	1.22e-05	0.000117	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CA2—osteoporosis	1.21e-05	0.000115	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—OXCT1—osteoporosis	1.21e-05	0.000115	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—IRS1—osteoporosis	1.2e-05	0.000115	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—GAPDH—osteoporosis	1.2e-05	0.000115	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—MGLL—osteoporosis	1.18e-05	0.000112	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—RAP1A—osteoporosis	1.17e-05	0.000112	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—POMC—osteoporosis	1.16e-05	0.000111	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—IL6R—osteoporosis	1.13e-05	0.000108	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—IGF1—osteoporosis	1.12e-05	0.000106	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—POMC—osteoporosis	1.11e-05	0.000106	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—IL6—osteoporosis	1.1e-05	0.000105	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—POMC—osteoporosis	1.02e-05	9.71e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—ENO1—osteoporosis	1e-05	9.57e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—IDH2—osteoporosis	1e-05	9.55e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PSMA5—osteoporosis	9.89e-06	9.43e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PSMA2—osteoporosis	9.89e-06	9.43e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—POMC—osteoporosis	9.88e-06	9.43e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—ENO1—osteoporosis	9.46e-06	9.02e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CYP27A1—osteoporosis	9.41e-06	8.98e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PSMA2—osteoporosis	9.32e-06	8.89e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PSMA5—osteoporosis	9.32e-06	8.89e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—ACP5—osteoporosis	9.15e-06	8.73e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—MYC—osteoporosis	8.68e-06	8.28e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—TGFB1—osteoporosis	8.66e-06	8.26e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—IL6—osteoporosis	8.53e-06	8.14e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—TPI1—osteoporosis	8.51e-06	8.12e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CYP19A1—osteoporosis	8.02e-06	7.65e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—P4HB—osteoporosis	8e-06	7.63e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GAPDH—osteoporosis	7.85e-06	7.49e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—RAP1A—osteoporosis	7.65e-06	7.3e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CYP19A1—osteoporosis	7.56e-06	7.21e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—MYC—osteoporosis	6.7e-06	6.4e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—TGFB1—osteoporosis	6.69e-06	6.38e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—ADCY5—osteoporosis	6.56e-06	6.25e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—GPX1—osteoporosis	6.53e-06	6.23e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—IL6—osteoporosis	6.53e-06	6.23e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—ENO1—osteoporosis	6.18e-06	5.9e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—ADCY5—osteoporosis	6.18e-06	5.89e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—GPX1—osteoporosis	6.16e-06	5.87e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PSMA2—osteoporosis	6.09e-06	5.81e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PSMA5—osteoporosis	6.09e-06	5.81e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—MTHFR—osteoporosis	6.03e-06	5.75e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—MTHFR—osteoporosis	5.68e-06	5.42e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—IL6—osteoporosis	5.04e-06	4.81e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CYP19A1—osteoporosis	4.94e-06	4.72e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—POMC—osteoporosis	4.82e-06	4.6e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—POMC—osteoporosis	4.54e-06	4.33e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—ADCY5—osteoporosis	4.04e-06	3.85e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GPX1—osteoporosis	4.02e-06	3.84e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—MTHFR—osteoporosis	3.71e-06	3.54e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—POMC—osteoporosis	2.97e-06	2.83e-05	CbGpPWpGaD
